Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Boston Scientific Corp (NYSE:BSX)

23.80
Delayed Data
As of Sep 30
 +0.50 / +2.15%
Today’s Change
15.67
Today|||52-Week Range
24.79
+29.07%
Year-to-Date
Boston Scientific to Buy EndoChoice, Boost Endoscopy Line
Sep 30 / Zacks.com - Paid Partner Content
Company News for September 28, 2016
Sep 28 / Zacks.com - Paid Partner Content
7 Healthcare Stocks in Focus on World Heart Day
Sep 29 / Zacks.com - Paid Partner Content
Boston Scientific's LOTUS Edge Valve System Gets CE Mark
Sep 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close23.30
Today’s open23.35
Day’s range23.24 - 23.91
Volume8,829,535
Average volume (3 months)9,427,411
Market cap$32.4B
Dividend yield--
Data as of 4:02pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-100.00%
Earnings growth (this year)+18.41%
Earnings growth (next 5 years)+10.50%
Revenue growth (last year)+1.25%
P/E ratioNM
Price/Sales3.34
Price/Book5.07

Competitors

 Today’s
change
Today’s
% change
BDXBecton Dickinson and...+3.29+1.86%
ZBHZimmer Biomet Holdin...+2.18+1.71%
BCRC R Bard Inc+0.54+0.24%
TFXTeleflex Inc+3.54+2.15%
Data as of 4:06pm ET, 09/30/2016

Financials

Next reporting dateOctober 20, 2016
EPS forecast (this quarter)$0.27
Annual revenue (last year)$7.4B
Annual profit (last year)-$239.0M
Net profit margin-3.23%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael F. Mahoney
Executive Vice President-
Operations
Edward Mackey
Corporate headquarters
Marlborough, Massachusetts

Forecasts

Search for Jobs